| Ashley Humble Wilson, FNP | |
|
2222 S Fayetteville St Ste B, Asheboro, NC 27205-7368 | |
| (336) 318-6200 | |
| Not Available |
| Full Name | Ashley Humble Wilson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2222 S Fayetteville St Ste B, Asheboro, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225522592 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 224424 (North Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 5010639 (North Carolina) | Primary |
| Entity Name | Five Points Medical Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760428551 PECOS PAC ID: 4082671300 Enrollment ID: O20041217000319 |
News Archive
Many international travelers to the 2016 Summer Olympics in Rio De Janeiro, Brazil, openly considered skipping the games to avoid the threat of Zika.
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium.
With "Size: Reduced. Fun: Amplified.", Roche Applied Science launched its new real-time PCR system on June 27th, 2011. The small, silent, sleek LightCycler Nano Instrument supports state-of-the-art technology for fast PCR protocols featuring leading edge thermal resolution and reproducibility.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's 13-valent pneumococcal conjugate vaccine.
› Verified 7 days ago
| Entity Name | County Of Randolph |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720011729 PECOS PAC ID: 0345413225 Enrollment ID: O20230503003462 |
News Archive
Many international travelers to the 2016 Summer Olympics in Rio De Janeiro, Brazil, openly considered skipping the games to avoid the threat of Zika.
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium.
With "Size: Reduced. Fun: Amplified.", Roche Applied Science launched its new real-time PCR system on June 27th, 2011. The small, silent, sleek LightCycler Nano Instrument supports state-of-the-art technology for fast PCR protocols featuring leading edge thermal resolution and reproducibility.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's 13-valent pneumococcal conjugate vaccine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Humble Wilson, FNP 1288 Old Mill Ford Trl, Asheboro, NC 27205-8262 Ph: (336) 953-3426 | Ashley Humble Wilson, FNP 2222 S Fayetteville St Ste B, Asheboro, NC 27205-7368 Ph: (336) 318-6200 |
News Archive
Many international travelers to the 2016 Summer Olympics in Rio De Janeiro, Brazil, openly considered skipping the games to avoid the threat of Zika.
Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium.
With "Size: Reduced. Fun: Amplified.", Roche Applied Science launched its new real-time PCR system on June 27th, 2011. The small, silent, sleek LightCycler Nano Instrument supports state-of-the-art technology for fast PCR protocols featuring leading edge thermal resolution and reproducibility.
Ocera Therapeutics, Inc. presented results yesterday from a Phase 2 proof-of-concept study of AST-120 (spherical carbon adsorbent) in the treatment of patients with non-constipating Irritable Bowel Syndrome (IBS) at DDW, the annual meeting of the American Gastroenterological Association. Data showed that subjects treated with AST-120 responded in a consistent manner with reduction in pain better than placebo at week four and at week eight, the primary time point for analysis. The company plans to initiate a Phase 2b study evaluating AST-120 in non-constipating IBS.
Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's 13-valent pneumococcal conjugate vaccine.
› Verified 7 days ago
Mr. Orlando Santiago Valenzuela Jr., AGNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 350 N Cox St Ste 6, Asheboro, NC 27203 Phone: 336-629-2201 | |
Marva Price, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2222 South Fayetteville Street, Randolph County Health Department, Asheboro, NC 27205 Phone: 336-318-3200 | |
Deanna Gay Markham, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 500 Albemarle Rd, Asheboro, NC 27203 Phone: 336-625-1172 | |
Dr. Susan A Fuller, DNP, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Mack Rd, Asheboro, NC 27205 Phone: 336-625-1172 Fax: 336-625-6434 | |
Whitney Clendenin, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 138 Dublin Square Rd Ste B, Asheboro, NC 27203 Phone: 336-489-3100 | |
Jennifer Jean Linney, RN, FNP, AGACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 138 Dublin Square Rd Ste B, Asheboro, NC 27203 Phone: 336-610-1300 | |
Fadielah Ruth Britt, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 610 N Fayetteville St Ste 300, Asheboro, NC 27203 Phone: 336-633-4020 |